Court rejects Healthscope
Tuesday, 02 September, 2008
The NSW Supreme Court has rejected Healthscope's [ASX: HSP] appeal for a break free from Symbion Health.
Healthscope, a private hospital operator which also owns some pathology businesses, had argued that pathology specialist Symbion should pay the company $19.5 million after reneging on a deal which would have seen Healthscope acquire Symbion's diagnostics business.
The court ordered that the break fee was not required. Healthscope is planning to lodge an appeal with the NSW Court of Appeal.
'Smart bandage' heals and monitors simultaneously
By embedding tiny, multi-functional nanomaterials into hydrogel dressing, this smart bandage...
This AI model judges molecular stability on its own, researchers say
Korean researchers have developed an artificial intelligence model that, they say, understands...
In the face of change: how Antarctic microbes can survive a 95°C temperature span
Analysis of microbial soil samples has helped Australian scientists understand the resilience of...
